Clinical Trial Update: A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-union [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating BMP-7 (OP-1) with demineralized bone matrix for tibial non-union has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonunion of Tibial Fracture

Drugs mentioned

• BMP-7 (OP-1) (bone morphogenetic protein-7)
• Demineralized Bone Matrix

Snippet

Sponsor: University Hospital, Ghent | Conditions: Non-union Diaphysary Tibial Fractures | Phase 4 | Status: TERMINATED